NORTH CHICAGO, Ill.,
June 26, 2019 /PRNewswire/ -- In
accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997,
Takeover Rules 2013, AbbVie Inc. confirms that as of June 24, 2019 its issued share capital, excluding
treasury shares, is comprised of 1,478,365,231 shares of common
stock with a par value of $0.01 per
share. AbbVie's common stock is traded on the NYSE and Chicago
Stock Exchange under the symbol ABBV. The International
Securities Identification Number (ISIN) of the AbbVie common stock
is US00287Y1091.
AbbVie confirms that, as of the close of business on
June 24, 2019, there were outstanding
6,845,326 options to purchase shares of common stock (the "Stock
Options"), 8,183,780 restricted stock units (the "Restricted Stock
Units") and 2,400,713 performance shares (the "Performance
Shares"). Upon exercise, each Stock Option entitles the holder to
purchase one share of common stock at the applicable exercise
price. Upon vesting, each Restricted Stock Unit and Performance
Share entitles the holder to receive one share of common stock.
The Directors of AbbVie Inc. accept responsibility for the
information contained in this announcement. To the best of their
knowledge and belief (having taken all reasonable care to ensure
such is the case), the information contained in this announcement
is in accordance with the facts and does not omit anything likely
to affect the import of such information.
Any holder of 1% or more of any class of relevant securities
of AbbVie Inc. may have disclosure obligations under Rule 8.3 of
the Irish Takeover Panel Act, 1997, Takeover Rules 2013.
View original
content:http://www.prnewswire.com/news-releases/abbvie-inc---rule-2-10-announcement---relevant-securities-in-issue-300874956.html
SOURCE AbbVie